SMTL ID : 8u2d.1

Bruton's tyrosine kinase in complex with N-[(2R)-1-[(3R)-3-(methylcarbamoyl)-1H,2H,3H,4H,9H-pyrido[3,4-b]indol-2-yl]-3-(3-methylphenyl)-1-oxopropan-2-yl]-1H-indazole-5-carboxamide

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 1.95 Å
Oligo State
monomer
Ligands
1 x UQX: (3R)-2-[N-(1H-indazole-5-carbonyl)-3-methyl-D-phenylalanyl]-N-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxamide(Non-covalent)
1 x NA: SODIUM ION(Non-functional Binders)
1 x CL: CHLORIDE ION(Non-functional Binders)
2 x SO4: SULFATE ION(Non-functional Binders)
1 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Robbins, D.W. et al., Discovery and Preclinical Pharmacology of NX-2127, an Orally Bioavailable Degrader of Bruton's Tyrosine Kinase with Immunomodulatory Activity for the Treatment of Patients with B Cell Malignancies. J.Med.Chem. (2024)
Release Date
2024-01-31
Peptides
Tyrosine-protein kinase BTK: A
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A

Tyrosine-protein kinase BTK

Related Entries With Identical Sequence

4zly.1 | 4zlz.1 | 8ejb.1 | 8gc7.1 | 8u2e.1